Trade Report: The Bbva Compass Bancshares Inc. Sold shares of Smith & Nephew PLC (SNN)

The Bbva Compass Bancshares Inc. Sold shares of Smith & Nephew PLC (SNN)

Bbva Compass Bancshares Inc. lowered its stake in shares of Smith & Nephew PLC (NYSE:SNN) by 2.4% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 45,393 shares of the company’s stock after selling 1,101 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Smith & Nephew PLC were worth $1,557,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in SNN. Highland Capital Management LLC raised its position in Smith & Nephew PLC by 5.6% in the second quarter. Highland Capital Management LLC now owns 18,824 shares of the company’s stock worth $646,000 after buying an additional 1,000 shares during the period. Ferguson Wellman Capital Management Inc. raised its position in Smith & Nephew PLC by 0.6% in the second quarter. Ferguson Wellman Capital Management Inc. now owns 240,202 shares of the company’s stock worth $8,244,000 after buying an additional 1,369 shares during the period. Eqis Capital Management Inc. raised its position in Smith & Nephew PLC by 3.0% in the second quarter. Eqis Capital Management Inc. now owns 23,799 shares of the company’s stock worth $817,000 after buying an additional 699 shares during the period. Augustine Asset Management Inc. raised its position in Smith & Nephew PLC by 2.1% in the second quarter. Augustine Asset Management Inc. now owns 98,515 shares of the company’s stock worth $3,381,000 after buying an additional 2,005 shares during the period. Finally, Curbstone Financial Management Corp raised its position in Smith & Nephew PLC by 1.0% in the second quarter. Curbstone Financial Management Corp now owns 35,550 shares of the company’s stock worth $1,220,000 after buying an additional 350 shares during the period. 5.88% of the stock is owned by institutional investors and hedge funds.

Smith & Nephew PLC (NYSE:SNN) traded down 1.40% during midday trading on Monday, hitting $30.31. The stock had a trading volume of 437,306 shares. Smith & Nephew PLC has a 52 week low of $30.10 and a 52 week high of $36.11. The stock has a 50-day moving average of $32.53 and a 200-day moving average of $33.52. The firm has a market cap of $13.55 billion, a P/E ratio of 38.17 and a beta of 0.68.

The business also recently disclosed a dividend, which will be paid on Tuesday, October 25th. Investors of record on Friday, October 7th will be paid a dividend of $0.236 per share. The ex-dividend date is Wednesday, October 5th.

SNN has been the subject of a number of recent analyst reports. Zacks Investment Research lowered Smith & Nephew PLC from a “hold” rating to a “sell” rating in a research report on Wednesday, July 6th. Barclays PLC lowered Smith & Nephew PLC from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, August 10th. Beaufort Securities reiterated a “hold” rating on shares of Smith & Nephew PLC in a research report on Wednesday, August 10th. Finally, Berenberg Bank lowered Smith & Nephew PLC from a “buy” rating to a “hold” rating in a research report on Thursday, October 6th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $37.00.

About Smith & Nephew PLC

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

Related posts

Leave a Comment